The Ethanolic Extract of Gomphrena celosioides Mart. Does Not Alter Reproductive Performance or Embryo-Fetal Development, nor Does It Cause Chromosomal Damage

Author(s):Show less -

Salustriano, Fabricia Rodrigues ; Duenhas Monreal, Antonio Carlos ; das Neves, Silvia Cordeiro ; de Oliveira, Giovana Martins ; Marques de Oliveira, Diego Duarte ; Brandao Vilela, Marcelo Luiz ; do Nascimento, Valter Aragao ; Faustino Martins, Allana Cristina ; Saroja, Baby ; Karuppusamy, Arunachalam ; Scherer Coelho, Henrique Rodrigues ; Leite Kassuya, Candida Aparecida ; Araque Gelves, Dayanna Isabel ; Salvador, Marcos Jose ; Oliveira, Rodrigo Juliano ; Gomes, Roberto da Silva

• Document type: Journal article
• Source: PHARMACEUTICS; v. 14, n. 11, p. 15-pg., 2022-11-01.

Abstract

Gomphrena celosioides is a native Brazilian plant found in the State of Mato Grosso do Sul. It is used in folk medicine to treat kidney diseases, skin diseases, infections, rheumatism, gastrointestinal diseases, and respiratory diseases. It is also used as an abortifacient. To evaluate the effects of the ethanolic extract of Gomphrena celosioides (EEGc) on reproductive performance, embryo development, and chromosome stability, Swiss mice were randomly divided into experimental groups (n = 10). The animals in the control group received the vehicle Tween 80-1% in the proportion of 0.1 mL/10 g of body weight orally, from the first to the 18th gestational day. The animals in the treatment groups received the EEGc (100, 1000, and 2000 mg/kg) from the first to the 18th gestational day. The animals underwent evaluations of their reproductive performance and embryofetal development. The results showed that the EEGc did not change the animals' final weight, weight gain, uterine weight, or net weight gain. The evaluation showed that the absolute and relative organs' weights did not vary between the different experimental groups. In addition, the EEGc did not change the numbers of implants, live fetuses, dead fetuses, or fetal resorptions. There were no differences in post-operative loss rates, implantations, or resorptions, nor were there differences in fetal viability or sex ratio. The use of the EEGc did not result in different frequencies of malformations. In addition, the EEGc did not alter the frequency of chromosomal damage or frequency of micronuclei. Based on our findings, we considered the extract of Gomphrena celosioides to be safe for use during pregnancy, although some parameters indicated caution in its use. (AU)

• FAPESP's process: 21/09693-5 - Use of microbiome technologies and bioassays for the search for new bioactive compounds in plants and symbionts: implications for metabolic responses, molecular diversity and bioactivity
• Grantee: Marcos José Salvador
• Support Opportunities: BIOTA-FAPESP Program - Regular Research Grants
• FAPESP's process: 06/06079-4 - Search of antioxidants and antimicrobials in Gomphreneae tribe species
• Grantee: Marcos José Salvador
• Support Opportunities: Regular Research Grants
• FAPESP's process: 15/03726-8 - Integrated chemical and biological study in the search for bioactive substances in plants* and development of analytical procedures. *(Amaranthaceae, Gesneriaceae, Myrtaceae e Annonaceae)
• Grantee: Marcos José Salvador
• Support Opportunities: Regular Research Grants